$16.92
Price
$878M
Market Cap
16.3
P/E Ratio
21.1
Forward P/E
$1.04
EPS (TTM)
—
Dividend Yield
$388M
Cash
$43M
Total Debt
52M
Shares Out
$12.27
$21.03
52-Week Range
Institutional Ownership of Theravance Biopharma Inc
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| No funds currently hold this stock. | |||||
Trading Activity for Theravance Biopharma Inc
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| 2024-Q3 | |||||
| SELL | EXIT | — | — | $8.24 | |
| 2024-Q2 | |||||
| SELL | -36.3% | 4.2M | $36M | $9.10 | |
| 2024-Q1 | |||||
| SELL | -11.1% | 6.6M | $59M | $8.98 | |
| 2023-Q2 | |||||
| SELL | -28.8% | 7.4M | $77M | $11.09 | |
| 2023-Q1 | |||||
| SELL | -8.8% | 10.4M | $113M | $10.59 | |
| 2022-Q4 | |||||
| SELL | -14.9% | 11.4M | $128M | $10.53 | |
| 2022-Q3 | |||||
| SELL | EXIT | — | — | $9.34 | |
| 2022-Q2 | |||||
| SELL | -1.6% | 13.4M | $122M | $9.10 | |
| SELL | -6.3% | 28.1M | $26M | $9.10 | |
| 2022-Q1 | |||||
| SELL | -0.1% | 13.6M | $130M | $9.68 | |
| 2021-Q3 | |||||
| BUY | +37.8% | 13.7M | $101M | $13.05 | |
| 2021-Q2 | |||||
| BUY | +13.4% | 9.9M | $144M | $18.63 | |
| 2020-Q3 | |||||
| SELL | -6.2% | 8.7M | $129M | $18.22 | |
Insider Trading for Theravance Biopharma Inc
No Insider Transactions
No Form 4 filings found for this stock in the last 2 years.